PharmaSGP to acquire four OTC brands from GSK

17 June 2021 - Deborah Wilkes

Premium

German consumer healthcare company PharmaSGP is acquiring a portfolio of four OTC brands in eight countries from GlaxoSmithKline (GSK) for around EUR80 million (USD95.5 million).

Click tags below for more information on topics:

PharmaSGP GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: